BridgeBio has substantially boosted its development of the novel therapy for ATTR-CM, utilizing Attruby. Early patient data reveals significant benefits for those suffering with a debilitating disease. The effort https://biotech115558.mybloglicious.com/62051052/company-improves-attr-cm-treatment-with-the-drug